Oaktree Specialty Lending Corp (OCSL) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001414932 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | — | $30.9M | $0.35 | Filing |
| Mar 31, 2026 | May 5, 2026 | — | $-18.9M | $-0.21 | Filing |
| Dec 31, 2025 | Feb 4, 2026 | — | $5.6M | $0.06 | Filing |
| Sep 30, 2025 | Nov 18, 2025 | — | $24.6M | $0.28 | Filing |
| Jun 30, 2025 | Aug 5, 2025 | — | $38.4M | $0.44 | Filing |
| Mar 31, 2025 | May 1, 2025 | — | $-36.2M | $-0.42 | Filing |
| Dec 31, 2024 | Feb 4, 2025 | — | $7.2M | $0.09 | Filing |
| Sep 30, 2024 | Nov 19, 2024 | — | $36.9M | $0.45 | Filing |
What would Oaktree Specialty Lending Corp have to report for its valuation to change?
At $11.78, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 16.0% a year, to $1.01. On that path the next quarter needs diluted EPS near $0.32, against $0.28 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 16.0% | 16.0% |
| EPS needed in final year | $1.01 | $1.01 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. OCSL goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.